Condensed Consolidated Statement of Stockholders’ Deficit - USD ($)	Series B Preferred Stock	Series A Preferred Stock	Common Stock	Additional Paid- in Capital	Accumulated (Deficit)	Total
Balance at Dec. 31, 2019		$ 83	$ 111,131	$ 19,322,864	$ (27,106,348)	$ (7,672,270)
Balance (in Shares) at Dec. 31, 2019		82,500	111,131,373
Settlement of derivative liabilities due to conversion
Net loss					(126,361)	(126,361)
Balance at Mar. 31, 2020		$ 83	$ 111,131	19,322,864	(27,232,709)	(7,798,631)
Balance (in Shares) at Mar. 31, 2020		82,500	111,131,373
Balance at Dec. 31, 2019		$ 83	$ 111,131	19,322,864	(27,106,348)	(7,672,270)
Balance (in Shares) at Dec. 31, 2019		82,500	111,131,373
Balance at Dec. 31, 2020		$ 83	$ 111,131	19,322,864	(28,014,231)	(8,580,153)
Balance (in Shares) at Dec. 31, 2020		82,500	111,131,373
Conversion of Series A preferred stock into Common Stock		$ (83)	$ 75,000	1,660,583		1,735,500
Conversion of Series A preferred stock into Common Stock (in Shares)		(82,500)	75,000,000
Conversion of related party debt into common stock			$ 677,904	14,787,149		15,465,053
Conversion of related party debt into common stock (in Shares)			677,903,545
Conversion of trade accounts payable into common stock			$ 52,880	1,321,991		1,374,871
Conversion of trade accounts payable into common stock (in Shares)			52,879,636
Conversion of trade accounts payable into Series B preferred stock	$ 397,964			63,903		63,903
Conversion of trade accounts payable into Series B preferred stock (in Shares)	397,964
Issuance of Series B stock for consulting services	$ 566,000
Issuance of Series B stock for consulting services (in Shares)	566,000
Settlement of derivative liabilities due to conversion				8,624		8,624
Net loss					(14,030,277)	(14,030,277)
Balance at Mar. 31, 2021	$ 963,964		$ 916,915	$ 37,165,114	$ (42,044,508)	$ (3,962,479)
Balance (in Shares) at Mar. 31, 2021	963,964		916,914,554